Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial): protocol of a randomized-controlled multicentric trial

Background: Quick symptomatic remission after the onset of psychotic symptoms is critical in schizophrenia treatment, determining the subsequent disease course and recovery. In this context, only every second patient with acute schizophrenia achieves symptomatic remission within three months of init...

Full description

Saved in:
Bibliographic Details
Main Authors: Wagner, Elias Maximilian (Author) , Strube, Wolfgang (Author) , Görlitz, Thomas (Author) , Aksar, Aslihan (Author) , Bauer, Ingrid (Author) , Campana, Mattia (Author) , Moussiopoulou, Joanna (Author) , Hapfelmeier, Alexander (Author) , Wagner, Petra (Author) , Egert-Schwender, Silvia (Author) , Bittner, Robert (Author) , Eckstein, Kathrin (Author) , Nenadić, Igor (Author) , Kircher, Tilo (Author) , Langguth, Berthold (Author) , Meisenzahl, Eva (Author) , Lambert, Martin (Author) , Neff, Sigrid (Author) , Malchow, Berend (Author) , Falkai, Peter (Author) , Hirjak, Dusan (Author) , Böttcher, Kent-Tjorben (Author) , Meyer-Lindenberg, Andreas (Author) , Blankenstein, Christiane (Author) , Leucht, Stefan (Author) , Hasan, Alkomiet (Author)
Format: Article (Journal)
Language:English
Published: September 2023
In: Pharmacopsychiatry
Year: 2023, Volume: 56, Issue: 05, Pages: 169-181
ISSN:1439-0795
DOI:10.1055/a-2110-4259
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1055/a-2110-4259
Verlag, lizenzpflichtig, Volltext: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-2110-4259
Get full text
Author Notes:Elias Wagner, Wolfgang Strube, Thomas Görlitz, Aslihan Aksar, Ingrid Bauer, Mattia Campana, Joanna Moussiopoulou, Alexander Hapfelmeier, Petra Wagner, Silvia Egert-Schwender, Robert Bittner, Kathrin Eckstein, Igor Nenadić, Tilo Kircher, Berthold Langguth, Eva Meisenzahl, Martin Lambert, Sigrid Neff, Berend Malchow, Peter Falkai, Dusan Hirjak, Kent-Tjorben Böttcher, Andreas Meyer-Lindenberg, Christiane Blankenstein, Stefan Leucht, Alkomiet Hasan

MARC

LEADER 00000caa a2200000 c 4500
001 189864523X
003 DE-627
005 20250917140440.0
007 cr uuu---uuuuu
008 240814s2023 xx |||||o 00| ||eng c
024 7 |a 10.1055/a-2110-4259  |2 doi 
035 |a (DE-627)189864523X 
035 |a (DE-599)KXP189864523X 
035 |a (OCoLC)1475307712 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wagner, Elias Maximilian  |d 1987-  |e VerfasserIn  |0 (DE-588)1121941214  |0 (DE-627)87502789X  |0 (DE-576)48105443X  |4 aut 
245 1 0 |a Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial)  |b protocol of a randomized-controlled multicentric trial  |c Elias Wagner, Wolfgang Strube, Thomas Görlitz, Aslihan Aksar, Ingrid Bauer, Mattia Campana, Joanna Moussiopoulou, Alexander Hapfelmeier, Petra Wagner, Silvia Egert-Schwender, Robert Bittner, Kathrin Eckstein, Igor Nenadić, Tilo Kircher, Berthold Langguth, Eva Meisenzahl, Martin Lambert, Sigrid Neff, Berend Malchow, Peter Falkai, Dusan Hirjak, Kent-Tjorben Böttcher, Andreas Meyer-Lindenberg, Christiane Blankenstein, Stefan Leucht, Alkomiet Hasan 
264 1 |c September 2023 
300 |b Illustrationen 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.08.2024 
520 |a Background: Quick symptomatic remission after the onset of psychotic symptoms is critical in schizophrenia treatment, determining the subsequent disease course and recovery. In this context, only every second patient with acute schizophrenia achieves symptomatic remission within three months of initiating antipsychotic treatment. The potential indication extension of clozapine—the most effective antipsychotic—to be introduced at an earlier stage (before treatment-resistance) is supported by several lines of evidence, but respective clinical trials are lacking. Methods: Two hundred-twenty patients with acute non-treatment-resistant schizophrenia will be randomized in this double-blind, 8-week parallel-group multicentric trial to either clozapine or olanzapine. The primary endpoint is the number of patients in symptomatic remission at the end of week 8 according to international consensus criteria (‘Andreasen criteria’). Secondary endpoints and other assessments comprise a comprehensive safety assessment (i. e., myocarditis screening), changes in psychopathology, global functioning, cognition, affective symptoms and quality of life, and patients’ and relatives’ views on treatment. Discussion:This multicentre trial aims to examine whether clozapine is more effective than a highly effective second-generation antipsychotics (SGAs), olanzapine, in acute schizophrenia patients who do not meet the criteria for treatment-naïve or treatment-resistant schizophrenia. Increasing the likelihood to achieve symptomatic remission in acute schizophrenia can improve the overall outcome, reduce disease-associated burden and potentially prevent mid- and long-term disease chronicity. 
700 1 |8 1\p  |a Strube, Wolfgang  |d 1986-  |e VerfasserIn  |0 (DE-588)1139181963  |0 (DE-627)896828018  |0 (DE-576)492972435  |4 aut 
700 1 |8 2\p  |a Görlitz, Thomas  |e VerfasserIn  |0 (DE-588)130739213X  |0 (DE-627)1868095347  |4 aut 
700 1 |a Aksar, Aslihan  |e VerfasserIn  |4 aut 
700 1 |8 3\p  |a Bauer, Ingrid  |d 1967-  |e VerfasserIn  |0 (DE-588)1208032410  |0 (DE-627)1694339491  |4 aut 
700 1 |a Campana, Mattia  |e VerfasserIn  |4 aut 
700 1 |a Moussiopoulou, Joanna  |e VerfasserIn  |4 aut 
700 1 |a Hapfelmeier, Alexander  |e VerfasserIn  |4 aut 
700 1 |a Wagner, Petra  |e VerfasserIn  |4 aut 
700 1 |a Egert-Schwender, Silvia  |e VerfasserIn  |4 aut 
700 1 |a Bittner, Robert  |e VerfasserIn  |4 aut 
700 1 |a Eckstein, Kathrin  |e VerfasserIn  |4 aut 
700 1 |a Nenadić, Igor  |e VerfasserIn  |4 aut 
700 1 |a Kircher, Tilo  |e VerfasserIn  |4 aut 
700 1 |a Langguth, Berthold  |e VerfasserIn  |4 aut 
700 1 |a Meisenzahl, Eva  |e VerfasserIn  |4 aut 
700 1 |a Lambert, Martin  |e VerfasserIn  |4 aut 
700 1 |a Neff, Sigrid  |e VerfasserIn  |4 aut 
700 1 |a Malchow, Berend  |e VerfasserIn  |4 aut 
700 1 |a Falkai, Peter  |e VerfasserIn  |4 aut 
700 1 |a Hirjak, Dusan  |d 1985-  |e VerfasserIn  |0 (DE-588)1024129306  |0 (DE-627)719194717  |0 (DE-576)367982463  |4 aut 
700 1 |a Böttcher, Kent-Tjorben  |e VerfasserIn  |4 aut 
700 1 |a Meyer-Lindenberg, Andreas  |d 1965-  |e VerfasserIn  |0 (DE-588)1029137390  |0 (DE-627)732483069  |0 (DE-576)376589876  |4 aut 
700 1 |a Blankenstein, Christiane  |d 1962-  |e VerfasserIn  |0 (DE-588)120425475  |0 (DE-627)69666464X  |0 (DE-576)292211899  |4 aut 
700 1 |a Leucht, Stefan  |e VerfasserIn  |0 (DE-588)1147997586  |0 (DE-627)100891469X  |0 (DE-576)496142976  |4 aut 
700 1 |8 4\p  |a Hasan, Alkomiet  |d 1982-  |e VerfasserIn  |0 (DE-588)137655428  |0 (DE-627)594517168  |0 (DE-576)304519200  |4 aut 
773 0 8 |i Enthalten in  |t Pharmacopsychiatry  |d Stuttgart [u.a.] : Thieme, 1984  |g 56(2023), 05, Seite 169-181  |h Online-Ressource  |w (DE-627)326977503  |w (DE-600)2041961-2  |w (DE-576)26359355X  |x 1439-0795  |7 nnas  |a Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial) protocol of a randomized-controlled multicentric trial 
773 1 8 |g volume:56  |g year:2023  |g number:05  |g pages:169-181  |g extent:13  |a Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial) protocol of a randomized-controlled multicentric trial 
856 4 0 |u https://doi.org/10.1055/a-2110-4259  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-2110-4259  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 3\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 4\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20240814 
993 |a Article 
994 |a 2023 
998 |g 1029137390  |a Meyer-Lindenberg, Andreas  |m 1029137390:Meyer-Lindenberg, Andreas  |d 60000  |e 60000PM1029137390  |k 0/60000/  |p 23 
998 |g 1024129306  |a Hirjak, Dusan  |m 1024129306:Hirjak, Dusan  |d 60000  |e 60000PH1024129306  |k 0/60000/  |p 21 
999 |a KXP-PPN189864523X  |e 4566002985 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"13 S.","noteIll":"Illustrationen"}],"recId":"189864523X","person":[{"display":"Wagner, Elias Maximilian","family":"Wagner","given":"Elias Maximilian","role":"aut"},{"display":"Strube, Wolfgang","role":"aut","given":"Wolfgang","family":"Strube"},{"display":"Görlitz, Thomas","given":"Thomas","role":"aut","family":"Görlitz"},{"family":"Aksar","given":"Aslihan","role":"aut","display":"Aksar, Aslihan"},{"display":"Bauer, Ingrid","given":"Ingrid","role":"aut","family":"Bauer"},{"display":"Campana, Mattia","role":"aut","given":"Mattia","family":"Campana"},{"display":"Moussiopoulou, Joanna","given":"Joanna","role":"aut","family":"Moussiopoulou"},{"display":"Hapfelmeier, Alexander","role":"aut","given":"Alexander","family":"Hapfelmeier"},{"role":"aut","given":"Petra","family":"Wagner","display":"Wagner, Petra"},{"display":"Egert-Schwender, Silvia","given":"Silvia","role":"aut","family":"Egert-Schwender"},{"family":"Bittner","given":"Robert","role":"aut","display":"Bittner, Robert"},{"role":"aut","given":"Kathrin","family":"Eckstein","display":"Eckstein, Kathrin"},{"display":"Nenadić, Igor","family":"Nenadić","role":"aut","given":"Igor"},{"family":"Kircher","role":"aut","given":"Tilo","display":"Kircher, Tilo"},{"family":"Langguth","given":"Berthold","role":"aut","display":"Langguth, Berthold"},{"display":"Meisenzahl, Eva","role":"aut","given":"Eva","family":"Meisenzahl"},{"given":"Martin","role":"aut","family":"Lambert","display":"Lambert, Martin"},{"role":"aut","given":"Sigrid","family":"Neff","display":"Neff, Sigrid"},{"role":"aut","given":"Berend","family":"Malchow","display":"Malchow, Berend"},{"display":"Falkai, Peter","given":"Peter","role":"aut","family":"Falkai"},{"display":"Hirjak, Dusan","family":"Hirjak","given":"Dusan","role":"aut"},{"family":"Böttcher","role":"aut","given":"Kent-Tjorben","display":"Böttcher, Kent-Tjorben"},{"role":"aut","given":"Andreas","family":"Meyer-Lindenberg","display":"Meyer-Lindenberg, Andreas"},{"family":"Blankenstein","given":"Christiane","role":"aut","display":"Blankenstein, Christiane"},{"display":"Leucht, Stefan","role":"aut","given":"Stefan","family":"Leucht"},{"family":"Hasan","role":"aut","given":"Alkomiet","display":"Hasan, Alkomiet"}],"relHost":[{"title":[{"subtitle":"clinical pharmacology, psychiatry, psychology, neurophysiology, neurobiology, gerontopsychiatry ; official organ of Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP)","title_sort":"Pharmacopsychiatry","title":"Pharmacopsychiatry"}],"part":{"issue":"05","text":"56(2023), 05, Seite 169-181","extent":"13","pages":"169-181","volume":"56","year":"2023"},"id":{"issn":["1439-0795"],"eki":["326977503"],"doi":["10.1055/s-00000054"],"zdb":["2041961-2"]},"note":["Gesehen am 05.07.22"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["17.1984 -"],"origin":[{"publisher":"Thieme","dateIssuedKey":"1984","dateIssuedDisp":"1984-","publisherPlace":"Stuttgart [u.a.]"}],"disp":"Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial) protocol of a randomized-controlled multicentric trialPharmacopsychiatry","recId":"326977503","physDesc":[{"extent":"Online-Ressource"}]}],"origin":[{"dateIssuedDisp":"September 2023","dateIssuedKey":"2023"}],"note":["Gesehen am 14.08.2024"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"subtitle":"protocol of a randomized-controlled multicentric trial","title_sort":"Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial)","title":"Effects of early clozapine treatment on remission rates in acute schizophrenia (the EARLY trial)"}],"name":{"displayForm":["Elias Wagner, Wolfgang Strube, Thomas Görlitz, Aslihan Aksar, Ingrid Bauer, Mattia Campana, Joanna Moussiopoulou, Alexander Hapfelmeier, Petra Wagner, Silvia Egert-Schwender, Robert Bittner, Kathrin Eckstein, Igor Nenadić, Tilo Kircher, Berthold Langguth, Eva Meisenzahl, Martin Lambert, Sigrid Neff, Berend Malchow, Peter Falkai, Dusan Hirjak, Kent-Tjorben Böttcher, Andreas Meyer-Lindenberg, Christiane Blankenstein, Stefan Leucht, Alkomiet Hasan"]},"id":{"doi":["10.1055/a-2110-4259"],"eki":["189864523X"]}} 
SRT |a WAGNERELIAEFFECTSOFE2023